Navigation Links
Federal Judicial Panel Considering Byetta Lawsuit Consolidation, Rottenstein Law Group LLP Reports
Date:8/25/2013

(PRWEB) August 25, 2013

The Byetta lawyers at Rottenstein Law Group LLP report that a federal judicial panel is still considering the consolidation of Byetta lawsuits, according to court documents. The Judicial Panel on Multidistrict Litigation was set to begin discussions on July 25 to investigate a consolidation of proceedings for pretrial efficiency.

Byetta, manufactured by Bristol-Myers Squibb subsidiary Amylin Pharmaceuticals, is designed to treat type-2 diabetes. The plaintiffs in the cases for the drugs all have common cause for suit, alleging that they suffered the same potentially dangerous side effects, such as pancreatitis and thyroid cancer, according to court documents in In RE: Incretin Mimetics Products Liability Litigation (MDL-2452; U.S. Judicial Panel on Multidistrict Litigation).

A March 2013 announcement* by the U.S. Food and Drug Administration mentioned findings similar to the allegations of the plaintiffs: That the drug caused inflammation of the pancreas and pre-cancerous changes to the cells of the pancreas. Byetta was also found to potentially increase the risk of thyroid cancer, according to the FDA.**

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged adverse side effects of Byetta to download a free brochure that features information about the drug’s side effects and lawsuits.

*http://www.fda.gov/Drugs/DrugSafety/ucm343187.htm
**http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190406.htm

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

                            ###

Read the full story at http://www.prweb.com/releases/byetta-lawsuits/pancreatic-cancer/prweb11057817.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Updated SSRI Birth Defects Lawsuits Allegations: Resource4thePeople Reports Cases Continue to Be Filed as Key Hearing Set in Consolidated Federal Litigation
2. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Settlement in Second Bellwether Trial in Federal C.R. Bard Mesh Litigation
3. DePuy Pinnacle Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Pinnacle Hip Litigation
4. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
5. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Latest Defense Motion in Federal DePuy ASR Recall Litigation
6. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Start of Second Bellwether Trial in Federal C.R. Bard Litigation
7. Mirena Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Orders in Federal Multidistrict Litigation for Mirena IUD Lawsuits
8. Biomet Hip Lawsuits Update: Almost 600 Lawsuits Pending in Federal Court, Reports Rottenstein Law Group LLP
9. America’s Health Insurance Announces Plans to Become a Registered and Certified Agent in the Federal Health Insurance Marketplace Exchange- Currently in Training
10. Vaginal Mesh Lawsuits Proceed Against Ethicon, as Bernstein Liebhard LLP Notes Order for Discovery Conferences in Federal Ethicon Litigation
11. Biomet Hip Lawsuits Mount, as Claims in Federal Litigation Approach 600, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 ... the lift is mounted on wheels, it can be wheeled out of the way and ... fasten to the deck. "We have transformed the feedback from customers into specific enhancements and ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
(Date:1/20/2017)... Florida (PRWEB) , ... January 20, 2017 , ... Lice ... head lice cases in families with school-aged children since the holiday season. , ... the holidays with their families, sharing hugs and taking photos, which is the head-to-head ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years of ... the clinical trial has been life-saving as she has been on the trial ... Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a ...
(Date:1/20/2017)... ... 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: a ... witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation ... educator interacting with countless women who had little knowledge of the female characters portrayed ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... , January 19, 2017 ... Option to Address Motor Symptoms and Motor Complications ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... , European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: